Feb 7th 2023 - Mar 21st 2023
If it doesn't happen and the story is still po... See more
but lets look at the facts: great results and pric... See more
Feb 8th 2023 - Mar 22nd 2023
My average is $8.18, so I will make a good profit ... See more
Wheres the $1k price target, u naiive bulls!!!! !
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.If it doesn't happen and the story is still positive and moving forward, my investment continues as I am pretty confident that we will get to the Jones Trading price target of $80pps.
but lets look at the facts: great results and price targets from $54-$80
Also like the fact that the drug intervenes in tau blocking as that is also a target in AD research.
$AVXL expect with positive results new price targets to fly in, $140 - $220 ! !
our study supports the idea that the sR1 is a promising therapeutic target for neurodegenerative retinal diseases, such as glaucoma.
My average is $8.18, so I will make a good profit if we get to $50 (realistic target).
Wheres the $1k price target, u naiive bulls!!!! !
Realistic targets
They have incredible management teams and are hitting all targets.
